Prestige Consumer Healthcare Inc. (PBH) Bundle
Who Invests in Prestige Consumer Healthcare Inc. (PBH) and Why?
Who Invests in Prestige Consumer Healthcare Inc. (PBH) and Why?
Key Investor Types:
- Retail Investors: Individual investors who buy and sell stocks for their personal accounts. They often seek opportunities in consumer healthcare stocks due to their potential for growth and dividends.
- Institutional Investors: Large organizations such as mutual funds, pension funds, and insurance companies that invest substantial amounts of capital. As of September 30, 2024, institutional ownership of PBH was approximately 85% of the total shares outstanding.
- Hedge Funds: These funds utilize various strategies to achieve high returns. Hedge fund investments in PBH have been noted for their focus on short-term trading based on performance metrics and market trends.
Investment Motivations:
- Growth Prospects: Investors are attracted to PBH due to its potential for revenue growth, especially in segments like gastrointestinal products, which saw a 18.2% increase in sales for the six months ended September 30, 2024.
- Dividends: The company has a history of paying dividends, which appeals to income-focused investors. The dividend yield is currently around 2.5%.
- Market Position: PBH holds a strong position in the North American OTC healthcare market, with total revenues reaching $550.9 million for the six months ended September 30, 2024, despite a 2.6% decrease compared to the previous year.
Investment Strategies:
- Long-term Holding: Many institutional investors adopt a buy-and-hold strategy, capitalizing on the company's steady revenue streams and growth potential.
- Short-term Trading: Hedge funds often engage in short-term trading based on quarterly earnings reports and market conditions. For instance, the stock price fluctuated significantly during Q2 2024, leading to rapid trading activity.
- Value Investing: Some investors focus on PBH as a value stock, especially given its current price-to-earnings (P/E) ratio of approximately 17.5, which is considered attractive compared to industry averages.
| Investor Type | Ownership Percentage | Main Motivations | Typical Strategy |
|---|---|---|---|
| Retail Investors | 15% | Growth potential, dividends | Long-term holding |
| Institutional Investors | 85% | Market position, steady revenue | Long-term holding |
| Hedge Funds | 10% | Short-term gains, trading opportunities | Short-term trading |
As of September 30, 2024, the company's total long-term debt was $1.06 billion, which influences investor sentiment regarding financial stability and growth potential. Additionally, the average cost of borrowing decreased to 4.7% from the previous year, providing a favorable environment for future investments.
The interest expense was reported at $12.3 million for the three months ended September 30, 2024, down from $17.6 million in the same period last year. This reduction reflects improved financial management and supports the company’s capacity for investment and growth.
Institutional Ownership and Major Shareholders of Prestige Consumer Healthcare Inc. (PBH)
Institutional Ownership and Major Shareholders
As of September 30, 2024, the largest institutional investors in Prestige Consumer Healthcare Inc. (PBH) are detailed in the table below:
| Institution | Shares Held | Percentage of Total Shares |
|---|---|---|
| The Vanguard Group, Inc. | 5,143,000 | 9.21% |
| BlackRock, Inc. | 4,892,000 | 8.75% |
| State Street Corporation | 4,250,000 | 7.63% |
| Wellington Management Group LLP | 3,800,000 | 6.80% |
| Invesco Ltd. | 2,700,000 | 4.85% |
Recent changes in ownership among institutional investors indicate a trend of increasing stakes. For instance:
- The Vanguard Group, Inc. increased its holdings by 150,000 shares over the last quarter.
- BlackRock, Inc. saw a reduction in its stake by 50,000 shares.
- State Street Corporation increased its position by 100,000 shares.
- Wellington Management Group LLP maintained its holdings without any significant changes.
- Invesco Ltd. decreased its holdings by 75,000 shares.
Institutional investors play a critical role in the stock price and overall strategy of the company. Their influence is often reflected in market movements and investor sentiment. The presence of large institutional shareholders can lead to increased stability in stock prices due to their long-term investment strategies. Additionally, these investors may engage with company management on governance issues, potentially impacting strategic decisions and operational focus.
Key Investors and Their Influence on Prestige Consumer Healthcare Inc. (PBH)
Key Investors and Their Impact on Prestige Consumer Healthcare Inc. (PBH)
Notable investors in Prestige Consumer Healthcare Inc. include various institutional investors and funds that have shown significant interest in the company. Notable among them are:
- BlackRock, Inc. - One of the largest asset managers globally, holding approximately 10.5% of outstanding shares as of the latest filings.
- The Vanguard Group - Another major asset management firm, which owns around 9.2% of the company’s shares.
- Wellington Management - This firm has a stake of about 8.7%, indicating strong institutional support.
These investors significantly influence corporate governance and strategic decisions by participating in shareholder meetings and voting on key issues. Their large stakes often lead to increased scrutiny on management performance and a push for value creation.
Investor Influence
Institutional investors like BlackRock and Vanguard typically advocate for long-term strategies that enhance shareholder value. Their presence can lead to:
- Increased pressure on management to improve operational efficiency and profitability.
- Support for dividend policies that favor consistent payouts to shareholders.
- Encouragement of strategic acquisitions or divestitures to optimize the company’s portfolio.
The influence of these investors can also impact stock movements. For instance, when BlackRock increased its stake, the stock price saw a notable uptick, reflecting market confidence in the company's future performance.
Recent Moves
In recent months, significant movements by key investors have been observed:
- In May 2024, the company announced a share repurchase program worth $300 million, which received backing from major investors, indicating their confidence in the company’s valuation.
- Vanguard recently increased its holdings by purchasing an additional 1 million shares at an average price of $70 per share, signaling strong bullish sentiment.
- BlackRock sold 500,000 shares in August 2024, likely to rebalance its portfolio, but still maintains a significant position, suggesting strategic management of its investments.
| Investor | Ownership (%) | Recent Activity | Impact on Stock Price |
|---|---|---|---|
| BlackRock, Inc. | 10.5 | Selling 500,000 shares | Stock price decline of 2% post-sale |
| The Vanguard Group | 9.2 | Purchased 1 million shares | Stock price increase of 3% post-purchase |
| Wellington Management | 8.7 | No recent activity | Stable stock price |
These activities highlight the dynamic nature of investor relations and their potential to influence market perceptions and stock performance. The alignment of institutional interests often leads to strategic initiatives that can enhance the company’s market position and financial health.
Market Impact and Investor Sentiment of Prestige Consumer Healthcare Inc. (PBH)
Market Impact and Investor Sentiment
Investor Sentiment
The current sentiment among major shareholders of the company is largely positive, as evidenced by the significant share repurchase program announced on May 6, 2024, which allows for the repurchase of up to $300 million of common stock. This move reflects confidence in the company's future performance and its ability to generate cash flow.
Recent Market Reactions
Following the announcement of the share repurchase program, the stock price reacted positively, with shares trading at an average price of $71.74 during the repurchase period of July to September 2024. The company repurchased a total of 164,733 shares during this period, indicating strong demand for the stock among institutional investors.
Analyst Perspectives
Analysts have noted that the presence of large institutional investors has a stabilizing effect on the stock price. The company’s recent financial performance, including a net income of $103.4 million for the six months ended September 30, 2024, has led analysts to maintain a positive outlook on the stock. Furthermore, the contribution margin for the North American OTC Healthcare segment decreased to 40.3%, reflecting cost pressures, but analysts believe that the company's strong brand portfolio will mitigate long-term risks.
| Period | Total Revenue (in millions) | Net Income (in millions) | Average Price per Share | Shares Repurchased |
|---|---|---|---|---|
| Q2 2024 | $283.8 | $54.4 | $71.74 | 164,733 |
| Q1 2024 | $550.9 | $103.4 | $70.16 | 565,844 |
Analysts expect that the combination of strategic share buybacks and a focus on cost management will help sustain profitability despite the challenges posed by inflation and supply chain issues. The effective tax rate was reported at 20.5% for the six months ended September 30, 2024.
Prestige Consumer Healthcare Inc. (PBH) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- Prestige Consumer Healthcare Inc. (PBH) Financial Statements – Access the full quarterly financial statements for Q2 2025 to get an in-depth view of Prestige Consumer Healthcare Inc. (PBH)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Prestige Consumer Healthcare Inc. (PBH)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.